69.82
1.26%
0.87
Handel nachbörslich:
69.82
Schlusskurs vom Vortag:
$68.95
Offen:
$68.95
24-Stunden-Volumen:
2.38M
Relative Volume:
1.52
Marktkapitalisierung:
$8.71B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
20.42
EPS:
3.42
Netto-Cashflow:
$421.00M
1W Leistung:
-8.85%
1M Leistung:
-5.30%
6M Leistung:
+4.91%
1J Leistung:
-4.88%
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
69.82 | 8.71B | 12.50B | 314.00M | 421.00M | 2.44 |
MCK
Mckesson Corporation
|
579.74 | 73.59B | 330.19B | 2.54B | 4.31B | 19.31 |
COR
Cencora Inc
|
227.69 | 44.01B | 293.96B | 1.51B | 3.00B | 7.51 |
CAH
Cardinal Health Inc
|
118.28 | 28.63B | 224.34B | 1.26B | 1.08B | 5.14 |
PDCO
Patterson Companies Inc
|
30.86 | 2.72B | 6.53B | 168.41M | -885.03M | 1.83 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-04 | Eingeleitet | Mizuho | Neutral |
2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
2023-11-10 | Hochstufung | Stifel | Hold → Buy |
2022-08-08 | Hochstufung | UBS | Sell → Neutral |
2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2019-04-18 | Eingeleitet | Guggenheim | Buy |
2019-01-17 | Eingeleitet | UBS | Sell |
2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2018-11-08 | Bestätigt | Barrington Research | Outperform |
2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
2018-10-19 | Fortgesetzt | Goldman | Neutral |
2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
2018-08-07 | Bestätigt | Stifel | Hold |
2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Henry Schein brings ‘Holiday Cheer’ - HME News
Should You Retain Henry Schein Stock in Your Portfolio Right Now? - MSN
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Is Henry Schein, Inc. (NASDAQ:HSIC) Potentially Undervalued? - Yahoo Finance
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
How Is The Market Feeling About Henry Schein? - Benzinga
Henry Schein to Participate at J.P. Morgan’s Healthcare Investor Conference - Dentistry Today
Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) Target Price at $78.89 - MarketBeat
Henry Schein to Present at J.P. Morgan Healthcare Conference 2025: Healthcare Solutions Leader Takes Center Stage - StockTitan
Henry Schein (HSIC) Up 6.4% Since Last Earnings Report: Can It Continue? - MSN
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein, Inc.'s (NASDAQ:HSIC) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Simply Wall St
Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Barclays PLC - MarketBeat
Toronto Dominion Bank Has $4.58 Million Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here's Why Henry Schein (HSIC) is a Strong Value Stock - MSN
On Our Island: Henry Schein spreads holiday cheer to LI families - Long Island Business News
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players? - Benzinga
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein: The Kind Of Business I Like But No Margin Of Safety Now (NASDAQ:HSIC) - Seeking Alpha
Foyston Gordon & Payne Inc Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
State Street Corp Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein, Inc. (NASDAQ:HSIC) Shares Bought by National Bank of Canada FI - MarketBeat
Henry Schein Acquires Acentus to Expand Homecare Medical Supplies Market - The Healthcare Technology Report.
Stifel Financial Corp Boosts Stake in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Edgestream Partners L.P. - MarketBeat
Centiva Capital LP Sells 15,802 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Mizuho sets Henry Schein target at $75 with neutral stance By Investing.com - Investing.com Canada
The Analyst Verdict: Henry Schein In The Eyes Of 4 Experts - Benzinga
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Holocene Advisors LP Acquires Shares of 799,981 Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Atom Investors LP Sells 8,543 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
New VeneerNow™ Injectable Matrix System Designed to Simplify Anterior Composite Restorations - Dental Products Report
Fmr LLC Buys 237,888 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
BNP Paribas Financial Markets Acquires 9,465 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Does Henry Schein (NASDAQ:HSIC) Have A Healthy Balance Sheet? - Simply Wall St
Isthmus Partners LLC Invests $701,000 in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Bridgewater Associates LP Has $4.32 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein extends gain on report of activist stake, push for board changes - MSN
Citigroup Inc. Trims Stake in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by The Manufacturers Life Insurance Company - MarketBeat
HSIC Gears Up for Q3 Earnings: Here's What You Need to Know - MSN
Zacks Research Forecasts Increased Earnings for Henry Schein - MarketBeat
FORA Capital LLC Buys 9,412 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Makes New $43.74 Million Investment in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Bank of Montreal Can Boosts Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term - MSN
Quantbot Technologies LP Purchases 42,419 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Are Wall Street Analysts Bullish on Henry Schein Stock? - MSN
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):